Jabil Posts Upbeat Q3 Results, Joins Uniqure, Braiin And Other Big Stocks Moving Higher On Wednesday
Intellia Therapeutics Inc NTLA
$15.67
▲ +3.09%
(+$0.47)
Open
$15.53
Prev Close
$15.20
Day Range
$15.04 – $16.20
52W Range
$7.95 – $28.25
Market Cap
$2.19B
Beta
1.80
EPS (TTM)
$-3.53
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-05-06 |
| Shares Out. | 139,720,000 |
| Website | intelliatx.com/ ↗ |
| Phone | 13026587581 |
Intellia Therapeutics Inc is a publicly traded company under the ticker symbol NTLA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
28 analysts (2026-06-01)
📰 Latest News for NTLA
Citizens Reiterates Market Outperform on Intellia Therapeutics, Maintains $30 Price Target
Wedbush Reiterates Neutral on Intellia Therapeutics, Maintains $12 Price Target
Intellia's One-Time Gene Editing Therapy Gains Ground Against Rivals In Rare Swelling Disorder
HC Wainwright & Co. Reiterates Buy on Intellia Therapeutics, Maintains $25 Price Target
Reported Saturday, Intellia Therapeutics' Lonvo-z Achieves 87% Attack Reduction And 62% Attack-Free Rate In Phase 3 HAELO Trial With Results Published Simultaneously In New England Journal Of Medicine